Brinker Capital Investments’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Brinker Capital Investments's BIIB Position: Q2 2026 in Review
Brinker Capital Investments increased its Biogen (BIIB) stake by 22% in Q2 2026, buying an estimated $356K and bringing the position to 10,358 shares worth $2.24M. The position accounts for 0.02% of the portfolio, ranked #738.
Brinker Capital Investments first reported a position in BIIB in Q3 2015 and has held it in 37 quarters since. The position peaked at $10.6M in Q2 2023. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Brinker Capital Investments held 10,358 shares of Biogen worth $2.24M as of Q2 2026.
- Brinker Capital Investments bought 1,861 Biogen shares in Q2 2026, an estimated $356K.
- Biogen made up 0.02% of Brinker Capital Investments's portfolio in Q2 2026, its #738 holding.
- Brinker Capital Investments first reported a position in Biogen in Q3 2015 and has held it in 37 quarters since.
- Brinker Capital Investments's Biogen position peaked at $10.6M in Q2 2023.
- 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.